Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Conditions

Cocaine Dependence

Trial Phase

Phase Pilot

Trial Purpose and Description

Trial Purpose

We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.


Participation Guidelines

Age:
18 Years - 50 Years
Gender:
Both

Eligibility Criteria

Inclusion Criteria:

  • Males and females between ages of 18 and 50
  • Enrolled in RNP methadone program and stable on methadone for at least 3 weeks
  • Current cocaine abuse or dependence according to DSM-IV criteria
  • No current medical problems and normal ECG
  • If female, not currently pregnant or breast feeding and using reliable birth control
  • Fluent in English and have at least a 6th grade reading level
  • Can commit to 12 weeks of treatment and are willing to be randomized

Exclusion Criteria:

  • Current major psychiatric illness including mood, psychotic or anxiety disorder
  • History of major medical illnesses including asthma, chronic obstructive lung disease, gastrointestinal ulcer, hepatic or renal impairment, cardiac rhythm disturbances
  • Use of medications including beta blockers and NASAIDs
  • Known allergy to Galantamine
Sponsor:
National Institute on Drug Abuse
Yale University
Dates:
08/30/2007
Last Updated:
Study HIC#:
0708002943